Compare Unichem Lab with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ASTRAZENECA PHARMA UNICHEM LAB/
ASTRAZENECA PHARMA
 
P/E (TTM) x -47.2 115.2 - View Chart
P/BV x 1.2 35.3 3.3% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 UNICHEM LAB   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
ASTRAZENECA PHARMA
Mar-18
UNICHEM LAB/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs2921,278 22.8%   
Low Rs182883 20.6%   
Sales per share (Unadj.) Rs167.7228.4 73.4%  
Earnings per share (Unadj.) Rs-3.610.4 -35.0%  
Cash flow per share (Unadj.) Rs5.916.3 36.5%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs372.398.8 376.9%  
Shares outstanding (eoy) m70.3825.00 281.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.44.7 29.9%   
Avg P/E ratio x-65.3104.2 -62.6%  
P/CF ratio (eoy) x39.966.4 60.0%  
Price / Book Value ratio x0.610.9 5.8%  
Dividend payout %-110.20-   
Avg Mkt Cap Rs m16,68027,008 61.8%   
No. of employees `0002.61.4 191.9%   
Total wages/salary Rs m2,3931,535 155.9%   
Avg. sales/employee Rs Th4,535.24,210.9 107.7%   
Avg. wages/employee Rs Th919.81,132.2 81.2%   
Avg. net profit/employee Rs Th-98.2191.1 -51.4%   
INCOME DATA
Net Sales Rs m11,8015,710 206.7%  
Other income Rs m984123 803.3%   
Total revenues Rs m12,7855,833 219.2%   
Gross profit Rs m-835463 -180.4%  
Depreciation Rs m674147 457.1%   
Interest Rs m750-   
Profit before tax Rs m-600438 -136.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-343179 -192.0%   
Profit after tax Rs m-256259 -98.6%  
Gross profit margin %-7.18.1 -87.3%  
Effective tax rate %57.340.8 140.2%   
Net profit margin %-2.24.5 -47.7%  
BALANCE SHEET DATA
Current assets Rs m20,3843,209 635.2%   
Current liabilities Rs m5,0292,070 243.0%   
Net working cap to sales %130.120.0 651.9%  
Current ratio x4.11.6 261.4%  
Inventory Days Days10572 144.8%  
Debtors Days Days13535 386.2%  
Net fixed assets Rs m9,023790 1,141.8%   
Share capital Rs m14150 281.6%   
"Free" reserves Rs m26,0582,419 1,077.1%   
Net worth Rs m26,1992,469 1,061.0%   
Long term debt Rs m00-   
Total assets Rs m31,4964,605 683.9%  
Interest coverage x-7.0NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.41.2 30.2%   
Return on assets %-0.65.6 -10.2%  
Return on equity %-1.010.5 -9.3%  
Return on capital %-2.017.7 -11.3%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,188300 2,733.4%   
Fx outflow Rs m5962,015 29.6%   
Net fx Rs m7,592-1,715 -442.6%   
CASH FLOW
From Operations Rs m-3,27888 -3,728.9%  
From Investments Rs m-2,860-94 3,055.7%  
From Financial Activity Rs m-24NA-  
Net Cashflow Rs m-4,690-6 82,284.2%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 15.1 0.3 5,033.3%  
FIIs % 3.0 15.7 19.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 9.1 348.4%  
Shareholders   20,176 12,856 156.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   VENUS REMEDIES  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  ORCHID PHARMA  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex Surged 1,147 Points Today(Closing)

Indian share markets continued their momentum and ended their day on a strong note today.

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Mar 3, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - FRESENIUS KABI ONCO. COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS